Ontology type: schema:ScholarlyArticle
2015-07
AUTHORSSasha Mazzarello, Brian Hutton, Mohammed F. K. Ibrahim, Carmel Jacobs, Risa Shorr, Stephanie Smith, Terry Ng, Mark Clemons
ABSTRACTSymptoms of urogenital atrophy are common in breast cancer survivors. Its optimal management is currently unknown. A systematic review of randomized controlled trials (RCTs) evaluating treatments for urogenital atrophy in breast cancer patients was performed. EMBASE, Ovid Medline and the Cochrane Library were searched from 1946 to November 2014. Outcomes included improvements in both vaginal symptoms (e.g., dryness, pain, dyspareunia and itching) and vaginal hormone response measured by validated scales [e.g., Vaginal Health Index (VHI) and Vaginal Maturation Index (VMI)]. Of 430 unique citations identified, 4 studies (n = 196) met inclusion criteria. Interventions included pH-balanced gel, Replens(®), lidocaine, Estring(®) and Vagifem(®). Sample sizes ranged from 7 to 98 patients. Given the heterogeneity of the studies, a narrative synthesis of results was performed. One study of 98 patients suggested that vaginal pH-balanced gel (mean VHI 5.00 ± 0.816, mean VMI 51.18 ± 3.753) was more efficient than placebo (VHI 16.98 ± 3.875, p < 0.001, VMI 47.87 ± 2.728, p < 0.001) at 12 weeks in providing vaginal symptom relief. In patients who used lidocaine, 90 % had reduced dyspareunia compared to saline in a study of 46 patients. Although increased serum estradiol occurred, both Estring(®) and Vagifem(®) were shown to improve quality of life and VMI in a study of seven patients. Treatment of urogenital atrophy remains a challenging issue and there is a paucity of RCT evidence addressing this knowledge gap. It is evident that more prospective trials are needed. More... »
PAGES1-8
http://scigraph.springernature.com/pub.10.1007/s10549-015-3434-z
DOIhttp://dx.doi.org/10.1007/s10549-015-3434-z
DIMENSIONShttps://app.dimensions.ai/details/publication/pub.1002984615
PUBMEDhttps://www.ncbi.nlm.nih.gov/pubmed/26003182
JSON-LD is the canonical representation for SciGraph data.
TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT
[
{
"@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json",
"about": [
{
"id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1103",
"inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/",
"name": "Clinical Sciences",
"type": "DefinedTerm"
},
{
"id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11",
"inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/",
"name": "Medical and Health Sciences",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Atrophy",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Breast Neoplasms",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Disease Management",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Female",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Female Urogenital Diseases",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Humans",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Randomized Controlled Trials as Topic",
"type": "DefinedTerm"
}
],
"author": [
{
"affiliation": {
"alternateName": "Ottawa Hospital",
"id": "https://www.grid.ac/institutes/grid.412687.e",
"name": [
"Cancer Therapeutics Program, Ottawa Hospital Research Institute, Ottawa, Canada"
],
"type": "Organization"
},
"familyName": "Mazzarello",
"givenName": "Sasha",
"id": "sg:person.0737376756.24",
"sameAs": [
"https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0737376756.24"
],
"type": "Person"
},
{
"affiliation": {
"alternateName": "Ottawa Hospital",
"id": "https://www.grid.ac/institutes/grid.412687.e",
"name": [
"Clinical Epidemiology Program, Ottawa Hospital Research Institute, Ottawa, Canada"
],
"type": "Organization"
},
"familyName": "Hutton",
"givenName": "Brian",
"id": "sg:person.01235465321.38",
"sameAs": [
"https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01235465321.38"
],
"type": "Person"
},
{
"affiliation": {
"name": [
"Division of Medical Oncology and Department of Medicine, The Ottawa Hospital Cancer Centre, University of Ottawa, 501 Smyth Road, Box 912, K1H 8L6, Ottawa, ON, Canada"
],
"type": "Organization"
},
"familyName": "Ibrahim",
"givenName": "Mohammed F. K.",
"id": "sg:person.012754470322.02",
"sameAs": [
"https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.012754470322.02"
],
"type": "Person"
},
{
"affiliation": {
"name": [
"Division of Medical Oncology and Department of Medicine, The Ottawa Hospital Cancer Centre, University of Ottawa, 501 Smyth Road, Box 912, K1H 8L6, Ottawa, ON, Canada"
],
"type": "Organization"
},
"familyName": "Jacobs",
"givenName": "Carmel",
"id": "sg:person.01036635505.66",
"sameAs": [
"https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01036635505.66"
],
"type": "Person"
},
{
"affiliation": {
"alternateName": "Ottawa Hospital",
"id": "https://www.grid.ac/institutes/grid.412687.e",
"name": [
"The Ottawa Hospital, Ottawa, Canada"
],
"type": "Organization"
},
"familyName": "Shorr",
"givenName": "Risa",
"id": "sg:person.01016010441.99",
"sameAs": [
"https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01016010441.99"
],
"type": "Person"
},
{
"affiliation": {
"alternateName": "Ottawa Hospital",
"id": "https://www.grid.ac/institutes/grid.412687.e",
"name": [
"Cancer Therapeutics Program, Ottawa Hospital Research Institute, Ottawa, Canada"
],
"type": "Organization"
},
"familyName": "Smith",
"givenName": "Stephanie",
"id": "sg:person.0651052101.37",
"sameAs": [
"https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0651052101.37"
],
"type": "Person"
},
{
"affiliation": {
"name": [
"Division of Medical Oncology and Department of Medicine, The Ottawa Hospital Cancer Centre, University of Ottawa, 501 Smyth Road, Box 912, K1H 8L6, Ottawa, ON, Canada"
],
"type": "Organization"
},
"familyName": "Ng",
"givenName": "Terry",
"id": "sg:person.01132237041.41",
"sameAs": [
"https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01132237041.41"
],
"type": "Person"
},
{
"affiliation": {
"alternateName": "Ottawa Hospital",
"id": "https://www.grid.ac/institutes/grid.412687.e",
"name": [
"Cancer Therapeutics Program, Ottawa Hospital Research Institute, Ottawa, Canada",
"Division of Medical Oncology and Department of Medicine, The Ottawa Hospital Cancer Centre, University of Ottawa, 501 Smyth Road, Box 912, K1H 8L6, Ottawa, ON, Canada"
],
"type": "Organization"
},
"familyName": "Clemons",
"givenName": "Mark",
"id": "sg:person.01216107435.90",
"sameAs": [
"https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01216107435.90"
],
"type": "Person"
}
],
"citation": [
{
"id": "https://doi.org/10.1016/j.ejca.2012.07.003",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1001308924"
],
"type": "CreativeWork"
},
{
"id": "https://doi.org/10.1634/theoncologist.2007-0234",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1004135901"
],
"type": "CreativeWork"
},
{
"id": "https://doi.org/10.1016/s0140-6736(12)61963-1",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1006312031"
],
"type": "CreativeWork"
},
{
"id": "https://doi.org/10.1016/0378-5122(95)00956-6",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1006921450"
],
"type": "CreativeWork"
},
{
"id": "sg:pub.10.1007/978-3-642-45769-2_38",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1014853163",
"https://doi.org/10.1007/978-3-642-45769-2_38"
],
"type": "CreativeWork"
},
{
"id": "https://doi.org/10.1097/aog.0b013e3182118790",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1020833086"
],
"type": "CreativeWork"
},
{
"id": "https://doi.org/10.1097/aog.0b013e3182118790",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1020833086"
],
"type": "CreativeWork"
},
{
"id": "https://doi.org/10.1097/aog.0b013e3182118790",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1020833086"
],
"type": "CreativeWork"
},
{
"id": "https://doi.org/10.3109/13697137.2012.756466",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1021288676"
],
"type": "CreativeWork"
},
{
"id": "https://doi.org/10.1016/j.maturitas.2011.09.003",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1022379007"
],
"type": "CreativeWork"
},
{
"id": "https://doi.org/10.1016/s0140-6736(04)15493-7",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1026400310"
],
"type": "CreativeWork"
},
{
"id": "https://doi.org/10.1093/jnci/dji071",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1030054143"
],
"type": "CreativeWork"
},
{
"id": "https://doi.org/10.1002/14651858.cd001500.pub2",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1031034848"
],
"type": "CreativeWork"
},
{
"id": "https://doi.org/10.1097/aog.0000000000000203",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1031629013"
],
"type": "CreativeWork"
},
{
"id": "https://doi.org/10.1097/aog.0000000000000203",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1031629013"
],
"type": "CreativeWork"
},
{
"id": "sg:pub.10.1023/a:1006263818115",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1032185952",
"https://doi.org/10.1023/a:1006263818115"
],
"type": "CreativeWork"
},
{
"id": "https://doi.org/10.1016/j.ajog.2010.08.035",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1033350385"
],
"type": "CreativeWork"
},
{
"id": "https://doi.org/10.1097/gme.0b013e31816c5541",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1033603119"
],
"type": "CreativeWork"
},
{
"id": "https://doi.org/10.1097/gme.0b013e31816c5541",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1033603119"
],
"type": "CreativeWork"
},
{
"id": "https://doi.org/10.1136/bmj.d5928",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1041893471"
],
"type": "CreativeWork"
},
{
"id": "sg:pub.10.1007/s00520-005-0847-y",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1041959587",
"https://doi.org/10.1007/s00520-005-0847-y"
],
"type": "CreativeWork"
},
{
"id": "sg:pub.10.1007/s00520-005-0847-y",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1041959587",
"https://doi.org/10.1007/s00520-005-0847-y"
],
"type": "CreativeWork"
},
{
"id": "sg:pub.10.1007/s00520-005-0847-y",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1041959587",
"https://doi.org/10.1007/s00520-005-0847-y"
],
"type": "CreativeWork"
},
{
"id": "https://doi.org/10.1016/j.clon.2012.06.009",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1043854024"
],
"type": "CreativeWork"
},
{
"id": "https://doi.org/10.1016/s1470-2045(08)70341-3",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1048840099"
],
"type": "CreativeWork"
},
{
"id": "https://doi.org/10.3816/cbc.2009.n.020",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1052388473"
],
"type": "CreativeWork"
},
{
"id": "https://doi.org/10.3109/13697137.2010.522875",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1052625955"
],
"type": "CreativeWork"
},
{
"id": "https://doi.org/10.1210/jcem.87.1.8141",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1064324808"
],
"type": "CreativeWork"
},
{
"id": "https://doi.org/10.1200/jco.1997.15.3.969",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1083057210"
],
"type": "CreativeWork"
}
],
"datePublished": "2015-07",
"datePublishedReg": "2015-07-01",
"description": "Symptoms of urogenital atrophy are common in breast cancer survivors. Its optimal management is currently unknown. A systematic review of randomized controlled trials (RCTs) evaluating treatments for urogenital atrophy in breast cancer patients was performed. EMBASE, Ovid Medline and the Cochrane Library were searched from 1946 to November 2014. Outcomes included improvements in both vaginal symptoms (e.g., dryness, pain, dyspareunia and itching) and vaginal hormone response measured by validated scales [e.g., Vaginal Health Index (VHI) and Vaginal Maturation Index (VMI)]. Of 430 unique citations identified, 4 studies (n = 196) met inclusion criteria. Interventions included pH-balanced gel, Replens(\u00ae), lidocaine, Estring(\u00ae) and Vagifem(\u00ae). Sample sizes ranged from 7 to 98 patients. Given the heterogeneity of the studies, a narrative synthesis of results was performed. One study of 98 patients suggested that vaginal pH-balanced gel (mean VHI 5.00 \u00b1 0.816, mean VMI 51.18 \u00b1 3.753) was more efficient than placebo (VHI 16.98 \u00b1 3.875, p < 0.001, VMI 47.87 \u00b1 2.728, p < 0.001) at 12 weeks in providing vaginal symptom relief. In patients who used lidocaine, 90 % had reduced dyspareunia compared to saline in a study of 46 patients. Although increased serum estradiol occurred, both Estring(\u00ae) and Vagifem(\u00ae) were shown to improve quality of life and VMI in a study of seven patients. Treatment of urogenital atrophy remains a challenging issue and there is a paucity of RCT evidence addressing this knowledge gap. It is evident that more prospective trials are needed.",
"genre": "research_article",
"id": "sg:pub.10.1007/s10549-015-3434-z",
"inLanguage": [
"en"
],
"isAccessibleForFree": false,
"isPartOf": [
{
"id": "sg:journal.1092777",
"issn": [
"0167-6806",
"1573-7217"
],
"name": "Breast Cancer Research and Treatment",
"type": "Periodical"
},
{
"issueNumber": "1",
"type": "PublicationIssue"
},
{
"type": "PublicationVolume",
"volumeNumber": "152"
}
],
"name": "Management of urogenital atrophy in breast cancer patients: a systematic review of available evidence from randomized trials",
"pagination": "1-8",
"productId": [
{
"name": "readcube_id",
"type": "PropertyValue",
"value": [
"0e368d6bf9a23c9f779b528f12f9499550d3ebe24dbfff15c9666893dc889299"
]
},
{
"name": "pubmed_id",
"type": "PropertyValue",
"value": [
"26003182"
]
},
{
"name": "nlm_unique_id",
"type": "PropertyValue",
"value": [
"8111104"
]
},
{
"name": "doi",
"type": "PropertyValue",
"value": [
"10.1007/s10549-015-3434-z"
]
},
{
"name": "dimensions_id",
"type": "PropertyValue",
"value": [
"pub.1002984615"
]
}
],
"sameAs": [
"https://doi.org/10.1007/s10549-015-3434-z",
"https://app.dimensions.ai/details/publication/pub.1002984615"
],
"sdDataset": "articles",
"sdDatePublished": "2019-04-10T23:23",
"sdLicense": "https://scigraph.springernature.com/explorer/license/",
"sdPublisher": {
"name": "Springer Nature - SN SciGraph project",
"type": "Organization"
},
"sdSource": "s3://com-uberresearch-data-dimensions-target-20181106-alternative/cleanup/v134/2549eaecd7973599484d7c17b260dba0a4ecb94b/merge/v9/a6c9fde33151104705d4d7ff012ea9563521a3ce/jats-lookup/v90/0000000001_0000000264/records_8693_00000510.jsonl",
"type": "ScholarlyArticle",
"url": "http://link.springer.com/10.1007%2Fs10549-015-3434-z"
}
]Download the RDF metadata as: json-ld nt turtle xml License info
JSON-LD is a popular format for linked data which is fully compatible with JSON.
curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1007/s10549-015-3434-z'
N-Triples is a line-based linked data format ideal for batch operations.
curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1007/s10549-015-3434-z'
Turtle is a human-readable linked data format.
curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1007/s10549-015-3434-z'
RDF/XML is a standard XML format for linked data.
curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1007/s10549-015-3434-z'
This table displays all metadata directly associated to this object as RDF triples.
227 TRIPLES
21 PREDICATES
59 URIs
28 LITERALS
16 BLANK NODES